Inventor
STEVENS KIRK L
US20 patents
⚠️ This page may combine multiple inventors who share the name “STEVENS KIRK L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
19 patentsUS9878995B2Jan 30, 2018
Cot modulators and methods of use thereof
GILEAD SCIENCES INC14 citations92
US11066414B2Jul 20, 2021
Cot modulators and methods of use thereof
GILEAD SCIENCES INC10 citations85
US11224600B2Jan 18, 2022
Compounds for inhibition of alpha 4 beta 7 integrin
GILEAD SCIENCES INC9 citations84
US10316017B2Jun 11, 2019
COT modulators and methods of use thereof
GILEAD SCIENCES INC12 citations84
US9815818B2Nov 14, 2017
Cot modulators and methods of use thereof
GILEAD SCIENCES INC13 citations84
US9765060B2Sep 19, 2017
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC13 citations83
US9376441B2Jun 28, 2016
Substituted pyrrolidines as SYK inhibitors
GILEAD SCIENCES INC17 citations82
US11905299B2Feb 20, 2024
Cot modulators and methods of use thereof
GILEAD SCIENCES INC3 citations74
US10221197B2Mar 5, 2019
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC2 citations72
US10005774B2Jun 26, 2018
Syk inhibitors
GILEAD SCIENCES INC4 citations72
US11179383B2Nov 23, 2021
Compounds for inhibition of α4β7 integrin
GILEAD SCIENCES INC3 citations71
US11116760B2Sep 14, 2021
Quinoline derivatives
GILEAD SCIENCES INC3 citations71
US12053462B2Aug 6, 2024
Quinoline derivatives
GILEAD SCIENCES INC0 citations61
US11174256B2Nov 16, 2021
Imidazopyridine derivatives
GILEAD SCIENCES INC2 citations61
US11578069B2Feb 14, 2023
Compounds for inhibition of α4 β7 integrin
GILEAD SCIENCES INC1 citations59
US11021467B2Jun 1, 2021
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC0 citations50
US9617310B2Apr 11, 2017
Inhibitors of hepatitis C virus
GILEAD SCIENCES INC0 citations50
US8367829B2Feb 5, 2013
Bi-functional pyrazolopyridine compounds
GILEAD SCIENCES INC0 citations49
US12410160B2Sep 9, 2025
KHK inhibitors
GILEAD SCIENCES INC0 citations46